| Name | Structure | Notes |
|---|---|---|
| 3β,5α-tetrahydrolevonorgestrel |
|
Estrogenic activity. Significantly reduced progestational activity. |
| 2α-hydroxylevonorgestrel |
|
Also present as glucuronide conjugate. |
| 13-ethyl-4-homogonane-3,17-dione |
|
Also present as sulfate and glucuronide conjugates. |
| 16β-hydroxy-3α,5β-tetrahydrolevonorgestrel |
|
Also present as sulfate and glucuronide conjugates. |
| 16β-Hydroxylevonorgestrel |
|
Sulfate conjugate also present, as well as the sulfate conjugate of the 16α stereoisomer. Metabolite of both levonorgestrel and norgestrel. |
| 3β,5β-tetrahydrolevonorgestrel |
|
Minor metabolite. Also present as a sulfate conjugate. |
| 3α,5β-tetrahydrolevonorgestrel |
|
Major metabolite. Also found as sulfate and glucuronide conjugates. |
| 3α,5α-tetrahydrolevonorgestrel |
|
"Much smaller" amount present than the primary metabolite 3α,5β-tetrahydrolevonorgestrel. Sulfate and glucuronide conjugates are also present. Tetrahydrometabolites of LNG are reported to show estrogenic activity in vitro. |